0001104659-21-136953.txt : 20211110
0001104659-21-136953.hdr.sgml : 20211110
20211110161724
ACCESSION NUMBER: 0001104659-21-136953
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211021
FILED AS OF DATE: 20211110
DATE AS OF CHANGE: 20211110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniels Eric Joseph
CENTRAL INDEX KEY: 0001892943
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 211396877
MAIL ADDRESS:
STREET 1: C/O EYEGATE PHARMACEUTICALS INC.
STREET 2: 271 WAVERLY OAKS RD., STE 108
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1371 EAST 2100 SOUTH
STREET 2: SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84105
BUSINESS PHONE: (781) 788-8869
MAIL ADDRESS:
STREET 1: 1371 EAST 2100 SOUTH
STREET 2: SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84105
FORMER COMPANY:
FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060811
4
1
tm2132572-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-10-21
0
0001372514
KIORA PHARMACEUTICALS INC
KPRX
0001892943
Daniels Eric Joseph
C/O KIORA PHARMACEUTICALS, INC.
1371 E. 2100 SOUTH, SUITE 200
SALT LAKE CITY
UT
84105
0
1
0
0
Chief Development Officer
Stock Option (right to buy)
1.99
2021-10-21
4
A
0
50000
0
A
2031-10-21
Common Stock
50000
50000
D
The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
/s/ Sarah Romano, Attorney-in-Fact*
2021-11-10